Results 131 to 140 of about 15,278 (221)

The Double-Edged Sword: How Evolution Can Make or Break a Live-Attenuated Virus Vaccine [PDF]

, 2011

core   +1 more source

Immunogenicity and safety of polio vaccines in infants: a systematic review of randomized clinical trials. [PDF]

Virol J
Terekhov RP, Svotin AA, Korochkina MD, Khodyachikh AA, Varnavskiy MA, Piniaeva AN, Ivin YY, Zhdanov DD, Kozlovskaya LI, Taldaev A.   +9 more
europepmc   +1 more source

Evaluation of hyper-attenuated S19 poliovirus strains for use in poliovirus neutralization assays. [PDF]

PLoS One
Wiese N, Hendley W, Jafri B, Jones KAV, Sifontes G, Valdez S, Zhang Y, Mainou BA.   +7 more
europepmc   +1 more source

Current status of BCG and OPV vaccination in children with primary immunodeficiency in Chongqing, China. [PDF]

Medicine (Baltimore)
Liu Y, Zhang Y, Ning Y, Zhang Z, Wang Q, Xie W, Yang H, Chen L, Zhao H, Xu J.   +9 more
europepmc   +1 more source

Safety and Immunogenicity of sIPV in Healthy Infants Aged 2 Months Following Sequential Immunization Program Combination with bOPV: A Phase 3, Randomized, Blinded, Parallel Positive-Controlled Clinical Trial. [PDF]

Vaccines (Basel)
Liu Y, Liu X, Zhang L, Chang X, Xiong P, Guan Y, Li Y, Zhang W, Xuan L, Li Y, Ying Z, Xu Q.   +11 more
europepmc   +1 more source

The final stage of developing genetically modified inactivated Sabin vaccine for the eradication of poliovirus [PDF]

, 2015
Poh, Chit Laa *, Yee, Isabel Pin Tsin *
core  

Population immunity to the three serotypes of poliovirus post-interruption of wild poliovirus transmission in Nigeria. [PDF]

J Virus Erad
Baba MM, Kawu AA, Bukar SA, Melton MS, Mala A, Salisu I, Oderinde BS.   +6 more
europepmc   +1 more source

The epidemiology of non-polio enteroviruses: recent advances and outstanding questions [PDF]

, 2015
Grassly, N, Parker, E, Pons Salort, M
core   +1 more source

Intramuscular versus intradermal administration of fractional dose inactivated poliovirus vaccine in Mozambique, 2020-2022: an, open-label, non-inferiority, randomised, controlled phase 2 trial. [PDF]

EClinicalMedicine
Omar Viegas E, Fumane E, Pereira K, Amade M, Jani I, Guilche O, Cubai C, Valdez S, Mainou BA, Lopez Cavestany R, Jeyaseelan V, Mach O.   +11 more
europepmc   +1 more source

The Pathogenesis and Virulence of the Major Enterovirus Pathogens Associated with Severe Clinical Manifestations: A Comprehensive Review. [PDF]

Cells
Liu Y, Maisimu M, Ge Z, Xiao S, Wang H.
europepmc   +1 more source